Cargando…
Lipid-based nanoparticles for cancer immunotherapy
As the fourth most important cancer management strategy except surgery, chemotherapy and radiotherapy, cancer immunotherapy has been confirmed to elicit durable antitumor effects in the clinic by leveraging the patient’s own immune system to eradicate the cancer cells. However, the limited populatio...
Autores principales: | Fan, Shumin, Han, Huize, Yan, Zhicheng, Lu, Yao, He, Bing, Zhang, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542882/ https://www.ncbi.nlm.nih.gov/pubmed/37789955 http://dx.doi.org/10.1515/mr-2023-0020 |
Ejemplares similares
-
Application of lipid-based nanoparticles in cancer immunotherapy
por: Zhang, Zhongkun, et al.
Publicado: (2022) -
Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
por: Han, Jieun, et al.
Publicado: (2023) -
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
por: Hao, Yang, et al.
Publicado: (2023) -
Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy
por: Wang, Hong-Li, et al.
Publicado: (2022) -
Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy
por: Zhang, Chi, et al.
Publicado: (2022)